Metallothionein-3 (MT-3) in the Human Adrenal Cortex and its Disorders

Endocrine Pathology

Volumn 25, Issue 3, 2014, Pages 229-235

  Felizola, Saulo J A ^a   Nakamura, Yasuhiro ^a   Arata, Yuki ^a   Ise, Kazue ^a   Satoh, Fumitoshi ^b   Rainey, William E ^c   Midorikawa, Sanae ^d   Suzuki, Shinichi ^d   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF MICHIGAN   (United States)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenal cortex; Adrenocortical adenoma; Aldosterone; Immunohistochemistry; Metallothionein; Zona glomerulosa

Indexed keywords

EID: 84887364508     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-013-9280-9     Document Type: Article

References (38)

1. Faller P. Neuronal growth-inhibitory factor (metallothionein-3): reactivity and structure of metal-thiolate clusters. FEBS J. 277:2921–2930, 2010.
2. Henkel G, Krebs B. Metallothioneins: zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features--structural aspects and biological implications. Chem Rev. 104:801–24, 2004.
3. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci. 59:627–647, 2002.
4. Palmiter RD. The elusive function of metallothioneins.Proc Natl Acad Sci U S A. 95:8428–8430, 1998.
5. Lee S, Koh J. Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Molecular Brain. 3:30, 2010.
6. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer’s disease brain is a 68 amino acid metallothionein-like protein. Neuron. 7:337–347, 1991.
7. Dutta R, Sens DA, Somji S, Sens MA, Garrett SH. Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells. Prostate. 52:89–97, 2002.
8. Garrett SH, Sens MA, Todd JH, Somji S, Sens DA. Expression of MT-3 protein in the human kidney. Toxicology letters. 105:207–214, 1999.
9. Hozumi I, Suzuki JS, Kanazawa H, Hara A, Saio M, Inuzuka T, Miyairi S, Naganuma A, Tohyama C. Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci Lett. 438:54–58, 2008.
10. Moffatt P, Séguin C. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol. 17:501–510, 1998.
11. Peng D, Hu TL, Jiang A, Washington MK, Moskaluk CA, Schneider-Stock R, El-Rifai W. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS One. 6:e22009, 2011.
12. Sens MA, Somji S, Garrett SH, Beall CL, Sens DA. Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. Am J Pathol. 159:21–26, 2001.
13. Somji S, Garrett SH, Zhou XD, Zheng Y, Sens DA, Sens MA. Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control. Toxicol Environ Chem. 92:1673–1695, 2010.
14. Werynska B, Pula B, Muszczynska-Bernhard B, Gomulkiewicz A, Jethon A, Podhorska-Okolow M, Jankowska R, Dziegiel P. Expression of metallothionein-III in patients with non-small cell lung cancer. Anticancer Res. 33:965–74, 2013.
15. Wang T, Satoh F, Morimoto R, Nakamura Y, Sasano H, Auchus RJ, Edwards MA, Rainey WE. Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Eur J Endocrinol. 164:613–619, 2011.
16. Szajerka A, Dziegiel P, Szajerka T, Zabel M, Winowski J, Grzebieniak Z. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex. Anticancer Res. 28:2959–2965, 2008.
17. Belloso E, Hernandez J, Giralt M, Kille CD, Hidalgo J. Effect of stress on mouse and rat brain metallothionein I and II mRNA levels. Neuroendocrinology. 64: 430–439, 1996.
18. El Ghazi I, Martin BL, Armitage IM. Metallothionein-3 is a component of a multiprotein complex in the mouse brain. Exp Biol Med. 231: 1500–1506, 2006.
19. Hidalgo J, Belloso E, Hernandez J, Gasull T, Molinero A. Role of glucocorticoids on rat brain metallothionein-I and –III response to stress. Stress 1: 231–240, 1997.
20. Kobayashi H, Uchida Y, Ihara Y, Nakajima K, Kohsaka S, Miyatake T, Tsuji S. Molecular cloning of rat growth inhibitory factor cDNA and the expression in the central nervous system. Brain Res Mol Brain Res. 19: 188–194, 1993.
21. Felizola SJA, Nakamura Y, Hui XG, Satoh F, Morimoto R, M McNamara K, Midorikawa S, Suzuki S, Rainey WE, Sasano H. Estrogen-related receptor α in normal adrenal cortex and adrenocortical tumors: involvement in development and oncogenesis. Mol Cell Endocrinol. 365:207–211, 2013.
22. Nogueira EF, Vargas CA, Otis M, Gallo-Payet N, Bollag WB, Rainey WE. Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells. J Mol Endocrinol. 39:365–374, 2007.
23. Hui XG, Akahira J, Suzuki T, Nio M, Nakamura Y, Suzuki H, Rainey WE, Sasano H. Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence. J Endocrinol. 203:241–252, 2009.
24. Ehrhart-Bornstein M, Hilbers U. Neuroendocrine properties of adrenocortical cells. Horm Metab Res. 30:436–439, 1998.
25. Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J Endocrinol. 195:39–48, 2007.
26. Felizola SJA, Nakamura Y, Satoh F, Morimoto R, Kikuchi K, Nakamura T, Hozawa A, Wang L, Onodera Y, Ise K, McNamara KM, Midorikawa S, Suzuki S, Sasano H. Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: The metabotropic pathway. Mol Cell Endocrinol. 382: 170–177, 2014. doi: 10.1016/j.mce.2013.09.025.
27. Papotti M, Volante M, Duregon E, Delsedime L, Terzolo M, Berruti A, Rosai J. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. Am J Surg Pathol. 34:973–983, 2010.
28. Hu C, Rusin CG, Tan Z, Guagliardo NA, Barrett PQ. Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J Clin Invest. 122:2046–2053, 2012.
29. Giorgi RR, Correa-Giannella ML, Casarini AP, Machado MC, Bronstein MD, Cescato VA, Giannella-Neto D. Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas. Neuroendocrinology. 82:208–214, 2005.
30. Peyre M, Commo F, Dantas-Barbosa C, Andreiuolo F, Puget S, Lacroix L, Drusch F, Scott V, Varlet P, Mauguen A, Dessen P, Lazar V, Vassal G, Grill J. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis. PLoS One. 5(9):e12932, 2010.
31. Zhou XD, Sens DA, Sens MA, Namburi VB, Singh RK, Garrett SH, Somji S. Metallothionein-1 and −2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer. Toxicol Sci. 91:467–475, 2006.
32. Fallo F, Barzon L, Biasi F, Altavilla G, Boscaro M, Sonino N. Zona fasciculata-like histotype and aldosterone response to upright posture are not related in aldosterone-producing adenomas. Exp Clin Endocrinol Diabetes. 106:74–78, 1998.
33. Gomez-Sanchez CE, Gomez-Sanchez EP. Aldosterone-producing adenomas: mining for genes. Hypertension. 55:1306–1307, 2010.
34. Kim HG, Hwang YP, Han EH, Choi CY, Yeo CY, Kim JY, Lee KY, Jeong HG. Metallothionein-III provides neuronal protection through activation of nuclear factor-kappaB via the TrkA/phosphatidylinositol-3 kinase/Akt signaling pathway. Toxicol Sci.112:435–449, 2009.
35. Su H, Gu Y, Li F, Wang Q, Huang B, Jin X, Ning G, Sun F. The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism. PLoS One. 8:e62399, 2013. doi: 10.1371/journal.pone.0062399.
36. Romero DG, Plonczynski M, Vergara GR, Gomez-Sanchez EP, Gomez-Sanchez CE. Angiotensin II early regulated genes in H295R human adrenocortical cells. Physiol Genomics. 19:106–116, 2004.
37. Nogueira EF, Rainey WE. Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology. 151:1060–1070, 2010.
38. Nogueira EF, Bollag WB, Rainey WE. Angiotensin II regulation of adrenocortical gene transcription. Mol Cell Endocrinol. 302:230–236, 2009.